PNC Financial Services Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,516
Closed -$332K 5127
2025
Q1
$332K Sell
2,516
-5,518
-69% -$728K ﹤0.01% 1823
2024
Q4
$671K Sell
8,034
-357
-4% -$29.8K ﹤0.01% 1355
2024
Q3
$614K Buy
8,391
+842
+11% +$61.6K ﹤0.01% 1409
2024
Q2
$517K Buy
7,549
+3,171
+72% +$217K ﹤0.01% 1458
2024
Q1
$303K Buy
4,378
+583
+15% +$40.3K ﹤0.01% 1878
2023
Q4
$272K Sell
3,795
-239
-6% -$17.1K ﹤0.01% 1936
2023
Q3
$210K Sell
4,034
-3,097
-43% -$161K ﹤0.01% 2088
2023
Q2
$452K Buy
7,131
+929
+15% +$58.8K ﹤0.01% 1636
2023
Q1
$336K Buy
6,202
+327
+6% +$17.7K ﹤0.01% 1797
2022
Q4
$311K Sell
5,875
-784
-12% -$41.5K ﹤0.01% 1838
2022
Q3
$310K Buy
6,659
+769
+13% +$35.8K ﹤0.01% 1810
2022
Q2
$336K Sell
5,890
-19
-0.3% -$1.08K ﹤0.01% 1798
2022
Q1
$363K Buy
5,909
+1,204
+26% +$74K ﹤0.01% 1882
2021
Q4
$246K Buy
4,705
+1,472
+46% +$77K ﹤0.01% 2127
2021
Q3
$121K Buy
3,233
+1,137
+54% +$42.6K ﹤0.01% 2513
2021
Q2
$86K Sell
2,096
-321
-13% -$13.2K ﹤0.01% 2745
2021
Q1
$83K Sell
2,417
-128
-5% -$4.4K ﹤0.01% 2694
2020
Q4
$82K Hold
2,545
﹤0.01% 2612
2020
Q3
$66K Buy
2,545
+321
+14% +$8.33K ﹤0.01% 2565
2020
Q2
$57K Hold
2,224
﹤0.01% 2692
2020
Q1
$35K Hold
2,224
﹤0.01% 2826
2019
Q4
$77K Buy
2,224
+158
+8% +$5.47K ﹤0.01% 2644
2019
Q3
$15K Sell
2,066
-95
-4% -$690 ﹤0.01% 3448
2019
Q2
$27K Buy
2,161
+95
+5% +$1.19K ﹤0.01% 3228
2019
Q1
$24K Hold
2,066
﹤0.01% 3291
2018
Q4
$23K Hold
2,066
﹤0.01% 3252
2018
Q3
$45K Hold
2,066
﹤0.01% 3057
2018
Q2
$37K Buy
2,066
+2,000
+3,030% +$35.8K ﹤0.01% 3187
2018
Q1
$2K Hold
66
﹤0.01% 4065
2017
Q4
$0 Buy
+66
New ﹤0.01% 4262
2016
Q4
Sell
-35,482
Closed -$541K 4111
2016
Q3
$541K Sell
35,482
-885
-2% -$13.5K ﹤0.01% 1519
2016
Q2
$1.41M Sell
36,367
-11,443
-24% -$444K ﹤0.01% 1103
2016
Q1
$1.33M Buy
47,810
+46,479
+3,492% +$1.29M ﹤0.01% 1134
2015
Q4
$71K Sell
1,331
-69
-5% -$3.68K ﹤0.01% 2648
2015
Q3
$56K Buy
+1,400
New +$56K ﹤0.01% 2828